{"nct_id":"NCT03709706","title":"Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab","status":"TERMINATED","status_verified_date":"2024-02","start_date":"2018-12-31","start_date_type":"ACTUAL","primary_completion_date":"2022-06-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-04","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}